Nilsson and colleagues showed that downregulation of MTHFD2 decreased cell proliferation in a panel of breast, central nervous system, colon, lung, melanoma, ovarian and renal cancer cell lines12. The gene discussed is MTHFD2; the disease is renal carcinoma.